Soybean (ZS)

最新ニュース Zscaler (NASDAQ:ZS) 株価情報

Zscaler

Zscaler is a software-as-a-service, or SaaS, firm focusing on providing cloud-native cybersecurity solutions to primarily enterprise customers. Zscaler's offerings can be broadly partitioned into Zscaler Internet Access, which provides secure access to external applications, and Zscaler Private Access, which provides secure access to internal applications. The firm is headquartered in San Jose, California, and went public in 2018.

Zscaler Inc

USCF ETF Trust USCF Sustainable Battery Metals Strategy Fund

USCF ETF Trust USCF Sustainable Commodity Strategy Fund

Innovator Equity Defined Protection ETF - 1 Yr September

ZHONGSHENG GP HL UNSP/ADR by Zhongsheng Group Holdings Ltd

Zhongsheng Group Holdings Ltd

ZENSHO HLDGS CO LTD by ZENSHO HLDGS CO LTD

Zensho Holdings Co Ltd

ProShares UltraShort Silver

ZSPACE Inc

ZSTAR ENTERPRISES INC by ZST Digital Networks, Inc.

ZST Digital Networks Inc

Smart Closet Inc

Morgan Stanley analyst Benjamin Swinburne maintains Clear Channel Outdoor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCO#NYSE">CCO</a>) with a Equal-Weight and lowers the price target from $2 to $1.5.

News

Price Target

Analyst Ratings

Morgan Stanley Maintains Equal-Weight on Clear Channel Outdoor, Lowers Price Target to $1.5

Morgan Stanley analyst Stephen Byrd maintains Bloom Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) with a Overweight and lowers the price target from $35 to $30.

Morgan Stanley Maintains Overweight on Bloom Energy, Lowers Price Target to $30

Moderna Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) reported on Thursday a first-quarter EPS loss of $(2.52), missing <a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">the consensus of $(3.12)</a>, down from an EPS loss of $(3.07) a year ago.
The COVID-19 vaccine maker reported quarterly sales of $108 million, down from $167 billion a year ago, beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/ac45128954/moderna-reports-first-quarter-2025-financial-results-and-provides-business-updates" rel="noreferrer noopener">consensus of $106.20 million</a>.
The decline was primarily driven by lower net product sales, which totaled $86 million in the quarter.
The reduction in product sales reflects lower vaccination rates compared to the same period last year and the continued normalization of COVID-19 into a seasonal commercial market, with demand expected to be concentrated in the second half of the year.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/health-care/25/04/45059756/trump-era-fda-appointees-request-new-trials-for-novavax-covid-vaccine-reportedly-delaying-approval-timeline" rel="noreferrer noopener">Trump-Era FDA Appointees Request New Trials For Novavax COVID Vaccine, Reportedly Delaying Approval Timeline</a>
The company reported $84 million in Spikevax sales in the first quarter of 2025, including $29 million in the U.S. and $55 million in international sales.
The company reported $2 million in mRESVIA sales in the first quarter of 2025. Moderna&#8217;s RSV vaccine for adults 60 and older was recently approved in Australia, <a href="https://www.benzinga.com/general/biotech/25/04/44876132/us-advisory-panel-votes-to-expand-recommendation-for-pfizer-gsks-rsv-vaccines-for-older-adults-below-60-years" target="_blank" rel="noreferrer noopener">Switzerland, Taiwan and the U.K</a>.
The cost of sales for the fourth quarter of 2024 was $739 million, which included third-party royalties of $45 million, inventory write-downs of $193 million, and wind-down costs of $259 million, including a non-cash charge of $238 million related to the termination of a contract manufacturing agreement.
Guidance:&nbsp;Moderna has reiterated its <a target="_blank" href="https://www.benzinga.com/general/biotech/25/02/43727537/moderna-struggles-with-declining-q4-covid-vaccine-sales-stock-slides" rel="noreferrer noopener">2025 revenue outlook</a> of $1.5 billion to $2.5 billion, compared to a consensus of $2.14 billion. Moderna expects revenue of approximately $0.2 billion in the first half of the year, reflecting the seasonality of its respiratory business.
Moderna expanded its cost efficiency and prioritization programs and expects estimated GAAP operating costs of $5.4 to $5.7 billion in 2026, a reduction from the company&#8217;s previous estimate of $5.9 billion.
The company is announcing a new 2027 GAAP operating cost estimate of $4.7 to $5 billion, reducing estimated operating costs by $1.4 to $1.7 billion by 2027 compared to its 2025 estimate.
Moderna shared Phase 3 immunogenicity data for its flu/COVID combination vaccine (mRNA-1083) for adults aged 50 and older at its 2024 R&amp;D Day event.&nbsp;
The company submitted mRNA-1083 for regulatory approval in older adults in 2024. Based on FDA feedback confirming the need for Phase 3 flu efficacy data, Moderna expects an extended review timeline and is now targeting approval in 2026.
Moderna has deprioritized its flu/COVID combination vaccine (mRNA-1083) for adults aged 18-49.
MRNA Price Action: Moderna stock was down 4.52% at $27.25 at publication on Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/05/45141818/hf-sinclair-overcomes-tariff-headwinds-sees-q1-strength-in-midstream-and-lubricants" target="_blank" rel="noreferrer noopener">HF Sinclair Overcomes Tariff Headwinds, Sees Q1 Strength In Midstream And Lubricants</a></li>
</ul>
Photo: Shutterstock

Biotech

Earnings

Government

Large Cap

Guidance

Health Care

Movers

Trading Ideas

General

MRNA

Moderna Expands Cost-Cutting Program By Up To $1.7 Billion, FDA Approval For Flu/COVID-19 Combo Shot Delayed Into 2026

JMP Securities analyst Greg Miller maintains The Hanover Insurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THG#NYSE">THG</a>) with a Market Outperform and raises the price target from $175 to $185.

JMP Securities Maintains Market Outperform on The Hanover Insurance Gr, Raises Price Target to $185

WIIM

Everest Group shares are trading lower after the company reported worse-than-expected Q1 financial results. Also, Evercore ISI Group maintained an In-Line rating on the stock and lowered its price target from $400 to $396.

Morgan Stanley analyst Meta Marshall maintains Arista Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>) with a Overweight and raises the price target from $73 to $100.

ANET

Morgan Stanley Maintains Overweight on Arista Networks, Raises Price Target to $100

JMP Securities analyst Greg Miller reiterates Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) with a Market Outperform and maintains $750 price target.

Reiteration

JMP Securities Reiterates Market Outperform on Meta Platforms, Maintains $750 Price Target

Morgan Stanley analyst Kristine Liwag maintains AerCap Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AER#NYSE">AER</a>) with a Equal-Weight and raises the price target from $101 to $111.

Morgan Stanley Maintains Equal-Weight on AerCap Holdings, Raises Price Target to $111

JMP Securities analyst Greg Miller reiterates Robinhood Markets (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) with a Market Outperform and maintains $70 price target.

HOOD

JMP Securities Reiterates Market Outperform on Robinhood Markets, Maintains $70 Price Target

Broadridge Financial Solutions shares are trading lower after the company reported mixed Q3 financial results.

Fortive shares are trading lower after the company reported Q1 sales results and issued Q2 adjusted EPS guidance below estimates. Also, the company lowered FY25 adjusted EPS guidance below estimates.

JMP Securities analyst Greg Miller reiterates Equinix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EQIX#NASDAQ">EQIX</a>) with a Market Outperform and maintains $1200 price target.

EQIX

JMP Securities Reiterates Market Outperform on Equinix, Maintains $1200 Price Target

JMP Securities analyst Greg Miller reiterates eBay (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBAY#NASDAQ">EBAY</a>) from Market Perform to Market Perform.

EBAY

JMP Securities Reiterates Market Perform on eBayto Market Perform

JMP Securities analyst Steven Delaney maintains DBV Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DBVT#NASDAQ">DBVT</a>) with a Market Outperform and raises the price target from $10 to $15.

DBVT

JMP Securities Maintains Market Outperform on DBV Technologies, Raises Price Target to $15

American Axle &amp; Mfg Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXL#NYSE">AXL</a>) will release its quarterly earnings report on Friday, 2025-05-02. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate American Axle &amp; Mfg Hldgs to report an earnings per share (EPS) of $0.07.
Investors in American Axle &amp; Mfg Hldgs are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Past Earnings Performance</h3>
The company's EPS beat by $0.05 in the last quarter, leading to a 0.0% drop in the share price on the following day.

<img src="https://www.benzinga.com/files/images/story/2025/1746119231_0.png" alt="eps graph" />
<h3>American Axle &amp; Mfg Hldgs Share Price Analysis</h3>
Shares of American Axle &amp; Mfg Hldgs were trading at $3.82 as of April 30. Over the last 52-week period, shares are down 49.2%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. 
<h3>Analyst Opinions on American Axle &amp; Mfg Hldgs</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on American Axle &amp; Mfg Hldgs.
The consensus rating for American Axle &amp; Mfg Hldgs is Neutral, derived from 5 analyst ratings. An average one-year price target of $5.7 implies a potential 49.21% upside.
<h3>Comparing Ratings Among Industry Peers</h3>
The analysis below examines the analyst ratings and average 1-year price targets of Holley, Gentherm and Fox Factory Holding, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Outperform trajectory for Holley, with an average 1-year price target of $4.0, suggesting a potential 4.71% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Gentherm, with an average 1-year price target of $31.33, suggesting a potential 720.16% upside.</li>
<li>Analysts currently favor an Buy trajectory for Fox Factory Holding, with an average 1-year price target of $30.6, suggesting a potential 701.05% upside.</li>
</ul>
<h3>Peer Analysis Summary</h3>
The peer analysis summary provides a snapshot of key metrics for Holley, Gentherm and Fox Factory Holding, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>American Axle &amp; Mfg Hldgs</td>
<td>Neutral</td>
<td>-5.62%</td>
<td>$154.30M</td>
<td>-2.24%</td>
</tr>
<tr>
<td>Holley</td>
<td>Outperform</td>
<td>-10.05%</td>
<td>$63.89M</td>
<td>-8.59%</td>
</tr>
<tr>
<td>Gentherm</td>
<td>Neutral</td>
<td>-0.61%</td>
<td>$86.47M</td>
<td>-0.02%</td>
</tr>
<tr>
<td>Fox Factory Holding</td>
<td>Buy</td>
<td>6.12%</td>
<td>$101.98M</td>
<td>-0.01%</td>
</tr>
</tbody>
</table>

Key Takeaway:
American Axle &amp; Mfg Hldgs ranks at the bottom for Revenue Growth among its peers. It is also at the bottom for Gross Profit and Return on Equity. The company's Consensus rating is neutral, placing it in the middle compared to its peers.
<h3>Discovering American Axle &amp; Mfg Hldgs: A Closer Look</h3>
American Axle &amp; Mfg Holdings Inc is engaged in manufacturing, engineering, designing, and validation of driveline systems and related components and chassis modules for light trucks, SUVs, crossover vehicles, passenger cars, and commercial vehicles. The company's segment includes Driveline and Metal Forming. It generates maximum revenue from the Driveline segment.
<h3>A Deep Dive into American Axle &amp; Mfg Hldgs's Financials</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Challenges: American Axle &amp; Mfg Hldgs's revenue growth over 3 months faced difficulties. As of 31 December, 2024, the company experienced a decline of approximately -5.62%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Discretionary sector.
Net Margin: American Axle &amp; Mfg Hldgs's net margin is impressive, surpassing industry averages. With a net margin of -0.96%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): American Axle &amp; Mfg Hldgs's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -2.24%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): American Axle &amp; Mfg Hldgs's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -0.25%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: American Axle &amp; Mfg Hldgs's debt-to-equity ratio surpasses industry norms, standing at 4.86. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<a href="https://www.benzinga.com/quote/AXL/earnings">To track all earnings releases for American Axle &amp; Mfg Hldgs visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insights Ahead: American Axle & Mfg Hldgs's Quarterly Earnings

<h3>Gainers</h3>
<ul>
<li>Classover Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KIDZ#NASDAQ">KIDZ</a>) shares increased by 184.3% to $3.27 during Thursday's regular session. The market value of their outstanding shares is at $72.8 million. </li>
<li>Yunji (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YJ#NASDAQ">YJ</a>) shares moved upwards by 22.06% to $1.77. The market value of their outstanding shares is at $34.8 million. </li>
<li>Stoneridge (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SRI#NYSE">SRI</a>) shares moved upwards by 18.65% to $4.58. The market value of their outstanding shares is at $126.8 million. The company's, Q1 earnings came out yesterday. </li>
<li>Upbound Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPBD#NASDAQ">UPBD</a>) shares rose 16.53% to $23.19. The company's market cap stands at $1.3 billion. As per the press release, Q1 earnings came out today. </li>
<li>Lotus Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOT#NASDAQ">LOT</a>) stock increased by 15.95% to $1.89. The market value of their outstanding shares is at $1.2 billion. </li>
<li>Vince Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNCE#NYSE">VNCE</a>) shares rose 15.39% to $1.97. The market value of their outstanding shares is at $24.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>E-Home Household Service (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EJH#NASDAQ">EJH</a>) stock decreased by 30.9% to $0.29 during Thursday's regular session. The market value of their outstanding shares is at $2.5 million. </li>
<li>Hamilton Beach Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HBB#NYSE">HBB</a>) shares fell 18.99% to $16.04. The company's market cap stands at $216.7 million. The company's, Q1 earnings came out yesterday. </li>
<li>Rocky Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCKY#NASDAQ">RCKY</a>) stock declined by 16.84% to $17.79. The company's market cap stands at $132.7 million. The company's, Q1 earnings came out 2 days ago. </li>
<li>Greenlane Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) stock fell 13.28% to $0.01. </li>
<li>Neo-Concept International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCI#NASDAQ">NCI</a>) stock fell 11.5% to $0.3. The company's market cap stands at $6.1 million. </li>
<li>LiveWire Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LVWR#NYSE">LVWR</a>) stock declined by 11.18% to $1.59. The company's market cap stands at $323.5 million. As per the press release, Q1 earnings came out today. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GNLN

KIDZ

LVWR

RCKY

UPBD

VNCE

12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>trivago (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRVG#NASDAQ">TRVG</a>) stock moved upwards by 28.9% to $5.36 during Thursday's regular session. The market value of their outstanding shares is at $374.9 million. The company's, Q1 earnings came out 2 days ago. </li>
<li>Direct Digital Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRCT#NASDAQ">DRCT</a>) stock moved upwards by 26.06% to $0.88. The company's market cap stands at $16.7 million. </li>
<li>TNL Mediagene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNMG#NASDAQ">TNMG</a>) shares rose 18.1% to $0.33. The company's market cap stands at $8.6 million. </li>
<li>FingerMotion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FNGR#NASDAQ">FNGR</a>) shares increased by 17.33% to $2.64. The market value of their outstanding shares is at $150.8 million. </li>
<li>Emerald Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EEX#NYSE">EEX</a>) shares increased by 16.66% to $4.58. The market value of their outstanding shares is at $915.1 million. As per the news, the Q1 earnings report came out today. </li>
<li>MediaAlpha (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAX#NYSE">MAX</a>) shares increased by 12.32% to $9.44. The company's market cap stands at $523.2 million. As per the press release, Q1 earnings came out yesterday. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Cumulus Media (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMLS#NASDAQ">CMLS</a>) stock decreased by 22.7% to $0.18 during Thursday's regular session. The market value of their outstanding shares is at $3.1 million. The company's, Q1 earnings came out today. </li>
<li>System1 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SST#NYSE">SST</a>) shares fell 17.76% to $0.48. The company's market cap stands at $35.4 million. </li>
<li>ATN International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATNI#NASDAQ">ATNI</a>) stock declined by 16.74% to $14.73. The company's market cap stands at $228.0 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>LiveOne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LVO#NASDAQ">LVO</a>) stock fell 13.81% to $0.76. The company's market cap stands at $72.7 million. </li>
<li>Urban One (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UONEK#NASDAQ">UONEK</a>) stock declined by 10.16% to $0.46. The company's market cap stands at $20.9 million. </li>
<li>Fluent (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNT#NASDAQ">FLNT</a>) shares decreased by 9.76% to $2.23. The market value of their outstanding shares is at $43.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ATNI

CMLS

DRCT

FLNT

FNGR

TNMG

TRVG

UONEK

12 Communication Services Stocks Moving In Thursday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>TransCode Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAZ#NASDAQ">RNAZ</a>) stock rose 80.5% to $0.73 during Thursday's regular session. The market value of their outstanding shares is at $17.1 million. </li>
<li>Healthcare Triangle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) stock moved upwards by 79.87% to $0.28. The company's market cap stands at $12.7 million. </li>
<li>NanoVibronix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAOV#NASDAQ">NAOV</a>) shares increased by 30.44% to $3.73. The company's market cap stands at $3.0 million. </li>
<li>Pheton Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTHL#NASDAQ">PTHL</a>) shares moved upwards by 29.48% to $4.04. The company's market cap stands at $58.5 million. </li>
<li>LogicMark (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGMK#NASDAQ">LGMK</a>) shares increased by 26.43% to $0.02. </li>
<li>HOOKIPA Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOK#NASDAQ">HOOK</a>) shares increased by 22.1% to $1.16. The company's market cap stands at $13.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Organon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OGN#NYSE">OGN</a>) stock fell 27.2% to $9.41 during Thursday's regular session. The market value of their outstanding shares is at $2.4 billion. As per the press release, Q1 earnings came out today. </li>
<li>Arvinas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARVN#NASDAQ">ARVN</a>) stock declined by 24.23% to $7.29. The market value of their outstanding shares is at $501.3 million. As per the press release, Q1 earnings came out today. </li>
<li>Kronos Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRON#NASDAQ">KRON</a>) stock declined by 22.75% to $0.69. The market value of their outstanding shares is at $42.0 million. </li>
<li>Phathom Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHAT#NASDAQ">PHAT</a>) stock decreased by 22.5% to $3.33. The company's market cap stands at $231.5 million. As per the press release, Q1 earnings came out today. </li>
<li>Pulmonx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNG#NASDAQ">LUNG</a>) shares decreased by 18.43% to $3.94. The company's market cap stands at $156.7 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>INVO Fertility (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVF#NASDAQ">IVF</a>) shares fell 18.42% to $1.95. The market value of their outstanding shares is at $9.6 million. As per the news, the Q4 earnings report came out 3 days ago. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ARVN

HCTI

HOOK

KRON

LGMK

LUNG

NAOV

PHAT

PTHL

RNAZ

12 Health Care Stocks Moving In Thursday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Zoomcar Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZCAR#NASDAQ">ZCAR</a>) shares rose 222.1% to $13.11 during Thursday's regular session. The company's market cap stands at $8.7 million. </li>
<li>Hong Kong Pharma Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HKPD#NASDAQ">HKPD</a>) shares rose 18.51% to $1.28. The company's market cap stands at $14.0 million. </li>
<li>Roma Green Finance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROMA#NASDAQ">ROMA</a>) shares increased by 17.19% to $1.43. The market value of their outstanding shares is at $22.2 million. </li>
<li>MYR Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYRG#NASDAQ">MYRG</a>) shares rose 16.79% to $142.87. The market value of their outstanding shares is at $2.3 billion. As per the news, the Q1 earnings report came out yesterday. </li>
<li>JFB Construction (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JFB#NASDAQ">JFB</a>) stock rose 13.55% to $4.69. The company's market cap stands at $43.3 million. </li>
<li>ZJK Industrial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZJK#NASDAQ">ZJK</a>) shares increased by 13.36% to $4.75. The company's market cap stands at $291.5 million. As per the news, the FY earnings report came out 3 days ago. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Titan Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWI#NYSE">TWI</a>) stock declined by 14.9% to $6.25 during Thursday's regular session. The market value of their outstanding shares is at $398.4 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>Singularity Future Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGLY#NASDAQ">SGLY</a>) shares declined by 14.84% to $0.9. The company's market cap stands at $3.7 million. </li>
<li>Distribution Solns Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DSGR#NASDAQ">DSGR</a>) shares decreased by 14.5% to $22.27. The company's market cap stands at $1.0 billion. As per the press release, Q1 earnings came out today. </li>
<li>Freight Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRGT#NASDAQ">FRGT</a>) shares decreased by 12.91% to $1.08. The market value of their outstanding shares is at $2.4 million. </li>
<li>FTAI Aviation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTAI#NASDAQ">FTAI</a>) shares declined by 12.58% to $93.64. The market value of their outstanding shares is at $9.6 billion. The company's, Q1 earnings came out yesterday. </li>
<li>Azul (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZUL#NYSE">AZUL</a>) shares decreased by 12.06% to $0.67. The company's market cap stands at $206.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AZUL

DSGR

FRGT

FTAI

HKPD

MYRG

ROMA

SGLY

ZCAR

12 Industrials Stocks Moving In Thursday's Intraday Session

BLND

Federal Savings Bank Expands Partnership With Blend Labs To Cut Rapid Refi Turnaround Time To Under 20 Minutes

Press Releases

Zscaler to Host Second Quarter Fiscal Year 2025 Earnings Conference Call

EY announces alliance with Zscaler to help secure and simplify digital transformations through cloud-delivered services

New Application Extends Zscaler Exposure Management Solution, Providing a Single Platform for Asset Risk Management, Prioritization and Quantification

Zscaler to Present at Upcoming Investor Conferences

Zscaler Reports Second Quarter Fiscal 2025 Financial Results

Economics

New Zscaler AI Security Report Reveals an Over 3,000% Surge in Enterprise Use of AI/ML Tools

2025 Entrepreneurship Summit Presented by the Harvard Undergraduate Venture Capital Group

Zscaler Zero Trust Exchange Platform Deployed Across T-Mobile Operations

Zscaler ThreatLabz 2025 VPN Risk Report: Over Half of Organizations Say Security and Compliance Risks Make VPNs Obsolete

Zscaler ThreatLabz Uncovers Surge in AI-Driven Cyberattacks Targeting Critical Business Operations

Comments

Zscaler

ニュース

最新ニュース Zscaler (NASDAQ:ZS) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル